Compass Ion Advisors’s CVS Health CVS Stock Holding History

Compass Ion Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$456K	Buy	4,408 +352	+9%	+$31.4K	0.04%	201
2026 Q1	$291K	Sell	4,056 -273	-6%	-$21K	0.03%	224
2025 Q4	$344K	Buy	4,329 +41	+1%	+$3.23K	0.03%	206
2025 Q3	$323K	Buy	4,288 +12	+0.3%	+$822	0.03%	217
2025 Q2	$295K	Sell	4,276 -897	-17%	-$58.8K	0.03%	215
2025 Q1	$350K	Sell	5,173 -540	-9%	-$32.3K	0.04%	197
2024 Q4	$256K	Sell	5,713 -4,238	-43%	-$238K	0.03%	224
2024 Q3	$626K	Sell	9,951 -527	-5%	-$30.7K	0.08%	145
2024 Q2	$836K	Hold	10,478	–	–	0.12%	98
2024 Q1	$836K	Sell	10,478 -461	-4%	-$35.2K	0.12%	99
2023 Q4	$864K	Buy	10,939 +904	+9%	+$64.3K	0.13%	98
2023 Q3	$701K	Buy	+10,035	New	+$711K	0.12%	112

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Compass Ion Advisors's CVS Position: Q2 2026 in Review

Compass Ion Advisors increased its CVS Health (CVS) stake by 8.7% in Q2 2026, buying an estimated $31.4K and bringing the position to 4,408 shares worth $456K. The position accounts for 0.04% of the portfolio, ranked #201.

Compass Ion Advisors first reported a position in CVS in Q3 2023 and has held it in 12 quarters since. The position peaked at $864K in Q4 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Compass Ion Advisors held 4,408 shares of CVS Health worth $456K as of Q2 2026.
Compass Ion Advisors bought 352 CVS Health shares in Q2 2026, an estimated $31.4K.
CVS Health made up 0.04% of Compass Ion Advisors's portfolio in Q2 2026, its #201 holding.
Compass Ion Advisors first reported a position in CVS Health in Q3 2023 and has held it in 12 quarters since.
Compass Ion Advisors's CVS Health position peaked at $864K in Q4 2023.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Compass Ion Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.